Effective 01 Jun this year,
Duodart (dutasteride/tamsulosin
hydrochloride) for the treatment
of moderate to severe benign
prostatic hyperplasia (BPH)
became available on the PBS so
that pharmacists can now counsel
potential patients to consult with
their GPs, instead of requiring a
referral to their urologist.
The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 16 Jun 16
To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 16 Jun 16
